glp-1 drug updates Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Dozens of new obesity drugs
Description
Funding This study was funded by University of Birmingham, UK, from 1 August 2016
( 10.1139/o71-122) [DOI] [PubMed] [Google Scholar] Buse JB Wexler DJ Tsapas A Rossing P Mingrone G Mathieu C D'Alessio DA & Davies MJ
10.1111/obr.70015 Obes Rev
Brakenridge SC, Moore FA, Mercier NR, Cox M, Wu Q, Moldawer LL, et al
A Final Word GLP-1 antagonist drugs have emerged as a novel therapeutic option for TIIDM
